Literature DB >> 26055010

An Evolving Understanding of the Genetic Causes of Abdominal Aortic Aneurysm Disease.

Grace H Miner1, Kevin D Costa1, Basil G Hanss1, Michael L Marin1.   

Abstract

Aneurysms of the abdominal aorta (AAA) are relatively common - affecting as many as 8% of men and 1% of women over the age of 65. AAAs are characterized by a 50% increase in the diameter of the aneurysmal aorta compared with the normal vessel. Degeneration of structural components of the aortic wall is believed to be central in the pathogenesis of AAAs. The exact mechanism of degeneration is not well characterized, although degradation of elastin and collagen has been clearly shown. At least six genetic variants have been associated with AAA in genome-wide association studies: CDKN2BAS1, DAB2IP, LDLR, LRP1, SORT1, and IL6R. These variants reach genome-wide significance; however, they have not been replicated in multiple cohorts, nor have they been clearly shown to be disease causative. AAA is a challenging disease for investigation because it is most often asymptomatic and generally has a late disease onset, making it difficult to diagnose. Determination of the genetic mechanism behind aneurysm formation, progression, and rupture crosses disciplines requiring input from multiple fields of study, larger patient cohorts, and the evolving modalities of genetic testing.

Entities:  

Mesh:

Year:  2015        PMID: 26055010

Source DB:  PubMed          Journal:  Surg Technol Int        ISSN: 1090-3941


  2 in total

1.  Correlation Between ABCA1 Gene Polymorphism and aopA-I and HDL-C in Abdominal Aortic Aneurysm.

Authors:  Lingfeng Zhao; Hui Jin; Bin Yang; Shichao Zhang; Shengbin Han; Fang Yin; Yaoyu Feng
Journal:  Med Sci Monit       Date:  2016-01-17

2.  99-Case Study of Sporadic Aortic Dissection by Whole Exome Sequencing Indicated Novel Disease-Associated Genes and Variants in Chinese Population.

Authors:  Zanxin Wang; Xianmian Zhuang; Bailang Chen; Junmin Wen; Fang Peng; Xiling Liu; Minxin Wei
Journal:  Biomed Res Int       Date:  2020-10-02       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.